Cargando…

Genetic variation in sodium glucose co‐transporter 1 and cardiac structure and function at middle age

AIMS: The effects of inhibition of sodium glucose cotransporter (SGLT)‐1, as opposed to SGLT2, on cardiovascular structure and function are not well known. We assessed the associations of a missense genetic variant of SGLT1 with cardiac structure and function. METHODS AND RESULTS: We evaluated assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bavishi, Aakash, Colangelo, Laura A., Rasmussen‐Torvik, Laura J., Lima, Joao A.C., Nannini, Drew R., Vaduganathan, Muthiah, Pandey, Ambarish, Lloyd‐Jones, Donald M., Shah, Sanjiv J., Patel, Ravi B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934939/ https://www.ncbi.nlm.nih.gov/pubmed/35166069 http://dx.doi.org/10.1002/ehf2.13841

Ejemplares similares

What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States
por: Aggarwal, Rahul, et al.
Publicado: (2021)

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298–2306
por: Segar, Matthew W., et al.
Publicado: (2020)

Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries
por: Sumarsono, Andrew, et al.
Publicado: (2020)

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
por: Usman, Muhammad Shariq, et al.
Publicado: (2022)

Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis
por: Sawicki, Konrad Teodor, et al.
Publicado: (2023)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure
por: Bavishi, Aakash, et al.
Publicado: (2020)

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
por: Essien, Utibe R., et al.
Publicado: (2023)

Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016
por: Khera, Rohan, et al.
Publicado: (2020)

Recognizing the importance of COVID-19 data wrangling
por: Rasmussen-Torvik, Laura J.
Publicado: (2022)

Time of day for COVID vaccine administration linked to clinical effectiveness
por: Rasmussen-Torvik, Laura J.
Publicado: (2023)

Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
por: Bhatt, Ankeet S., et al.
Publicado: (2020)

A rationale for dedicated trials of combination therapy in heart failure
por: Blumer, Vanessa, et al.
Publicado: (2022)

Closer to FREEDOM From Uncertainty
por: Vaduganathan, Muthiah, et al.
Publicado: (2023)

Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters
por: Armour, Sarah L., et al.
Publicado: (2022)

Trends, Management, and Outcomes of Acute Myocardial Infarction Hospitalizations With In‐Hospital‐Onset Versus Out‐of‐Hospital Onset: The ARIC Study
por: Caughey, Melissa C., et al.
Publicado: (2021)

Manual Thrombectomy in Myocardial Infarction: Aspiring for Better
por: Vaduganathan, Muthiah, et al.
Publicado: (2015)

Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction
por: Ostrominski, John W., et al.
Publicado: (2022)

Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018
por: Salah, Husam M., et al.
Publicado: (2022)

Does Lowering Low‐Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle‐Aged Adults? Analysis of the Observational MESA Study
por: Liu, Kiang, et al.
Publicado: (2021)

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
por: Vaduganathan, Muthiah, et al.
Publicado: (2019)

In Reply to Loh and Lin:
por: Vaduganathan, Muthiah, et al.
Publicado: (2014)

Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019
por: Leiva, Orly, et al.
Publicado: (2020)

Cardio-Renal-Metabolic Care Models: Toward Achieving Effective Interdisciplinary Care
por: Rangaswami, Janani, et al.
Publicado: (2020)

Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology
por: Chatur, Safia, et al.
Publicado: (2023)

COVID-19: the Risk to Athletes
por: Goergen, Jack, et al.
Publicado: (2021)

Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney
por: Harada, Norio, et al.
Publicado: (2012)

Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program
por: McCarthy, Cian P., et al.
Publicado: (2019)

Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study
por: Arora, Sameer, et al.
Publicado: (2020)

Peripubertal Anti-Mullerian Hormone Levels Are Associated With Hyperandrogenemia During Adolescence: The Avon Longitudinal Study of Parents and Children
por: Dieguez, Abigayil, et al.
Publicado: (2021)

Picking Up the Torch: Our Mission as the New FIT & EC Section Editors
por: Yong, Celina M., et al.
Publicado: (2020)

Addressing Equity and More in 2021: Call From Fellows-in-Training & Early Career Section Editors
por: Han, Jason J., et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review
por: Roth, Gregory A., et al.
Publicado: (2022)

Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease
por: Mensah, George A., et al.
Publicado: (2023)

Association of a Fasting Glucose Genetic Risk Score With Subclinical Atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study
por: Rasmussen-Torvik, Laura J., et al.
Publicado: (2011)

Effect of government-issued state of emergency and reopening orders on cardiovascular hospitalizations during the COVID-19 pandemic
por: Arora, Sameer, et al.
Publicado: (2021)

Systemic Inflammation in Young Adults Is Associated with Abnormal Lung Function in Middle Age
por: Kalhan, Ravi, et al.
Publicado: (2010)

Physician Density by Specialty Type in Urban and Rural Counties in the US, 2010 to 2017
por: Machado, Sara R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_96upngmgpnimvdlmibfemfqscl